LLY
$LLY
Eli Lilly and Company
Pharmaceutical heavyweight known for weight-loss drugs Mounjaro and Zepbound.
Healthcare$935.58
-18.94 (-1.98%)
Day Range$930.02 - $957.69
Prev Close$954.52
Analyst Rating
Strong Buy
30 Buy / 8 Hold / 1 Sell
Subscribers
8
Tracking this ticker
Next Report
Sun, Apr 12
Weekly updates
Latest Report
LLY: GLP-1 Approval Fuels Growth (LLY)
Eli Lilly's FDA approval for a new oral GLP-1 pill and continued strength in Mounjaro and Zepbound underpin a bullish growth narrative. High valuation and competitive risks warrant caution.
Apr 1, 2026